Charles F. Wagner, Jr.

Executive Vice President and Chief Operating & Financial Officer (Principal Financial Officer), Vertex Pharmaceuticals Incorporated

Leaving, effective January 1, 2027. First published here October 28, 2026; built from records as of October 28, 2026.

Charles F. Wagner, Jr. is leaving the chief financial officer seat at Vertex Pharmaceuticals Incorporated: the company's filing of September 1, 2026 gives January 1, 2027 as the effective date.² The same filing names Jonathan Poole as the successor.²

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Vertex Pharmaceuticals Incorporated (VRTX) Pharmaceutical Preparations	Executive Vice President and Chief Operating & Financial Officer (Principal Financial Officer)	Leaving, effective January 1, 2027	2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

January 1, 2027takes effect
Vertex Pharmaceuticals Incorporated named Jonathan Poole to succeed Charles F. Wagner, Jr., effective January 1, 2027. Profile of Jonathan Poole.
[2] Filing by Vertex Pharmaceuticals Incorporated, filed with the SEC on September 1, 2026. Read the filing. The record at CFO Tribune.
February 13, 202610-K filed
Charles F. Wagner, Jr. signed the annual report of Vertex Pharmaceuticals on Form 10-K as Executive Vice President and Chief Operating & Financial Officer (Principal Financial Officer), filed February 13, 2026.
/s/ Charles F. Wagner, Jr. Charles F. Wagner, Jr. Executive Vice President and Chief Operating & Financial Officer (Principal Financial Officer)
[1] Annual report on Form 10-K by Vertex Pharmaceuticals, filed with the SEC on February 13, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Vertex Pharmaceuticals. U.S. Securities and Exchange Commission, EDGAR, filed February 13, 2026. sec.gov; record.
Current report filed with the SEC, Vertex Pharmaceuticals Incorporated. U.S. Securities and Exchange Commission, EDGAR, filed September 1, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Charles F. Wagner, Jr. wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.